Carbamylation modification of lysine residues of ApoA-I rendered HDL dysfunction and was associated with increased mortality outcomes in patients with type 2 diabetes.87 The disordered metabolism of LDL in CKD includes increased levels and post-translational modifications. This evidence concerns the gene APOA1 and chronic kidney disease.